CTSO CytoSorbents Corporation
CytoSorbents Corporation (CTSO) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.04 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.2% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About CytoSorbents Corporation
Cytosorbents Corp is a development stage company. The Company, through its subsidiary, is engaged in the research, development and commercialization of medical devices.
Sector
Healthcare
Industry
Medical Instruments/Supply